Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
30725 | 134 | 27.8 | 67% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
554 | 13833 | CEREBRAL ISCHEMIA//SPREADING DEPRESSION//ISCHEMIC TOLERANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LUBELUZOLE | Author keyword | 28 | 69% | 18% | 24 |
2 | KR 31378 | Author keyword | 8 | 60% | 7% | 9 |
3 | AGROPHARMA | Address | 7 | 46% | 9% | 12 |
4 | KR 31831 | Author keyword | 6 | 71% | 4% | 5 |
5 | 21ST CENTURY FRONTIER PROGRAM | Address | 4 | 75% | 2% | 3 |
6 | KR 31543 | Author keyword | 4 | 75% | 2% | 3 |
7 | ANGIOENCEPHALOPATHY | Author keyword | 3 | 100% | 2% | 3 |
8 | PROD PHARMACEUT RAW MAT | Address | 1 | 100% | 1% | 2 |
9 | BIOL MODULATORS | Address | 1 | 30% | 2% | 3 |
10 | EXCYTOTOXICITY | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LUBELUZOLE | 28 | 69% | 18% | 24 | Search LUBELUZOLE | Search LUBELUZOLE |
2 | KR 31378 | 8 | 60% | 7% | 9 | Search KR+31378 | Search KR+31378 |
3 | KR 31831 | 6 | 71% | 4% | 5 | Search KR+31831 | Search KR+31831 |
4 | KR 31543 | 4 | 75% | 2% | 3 | Search KR+31543 | Search KR+31543 |
5 | ANGIOENCEPHALOPATHY | 3 | 100% | 2% | 3 | Search ANGIOENCEPHALOPATHY | Search ANGIOENCEPHALOPATHY |
6 | EXCYTOTOXICITY | 1 | 50% | 1% | 1 | Search EXCYTOTOXICITY | Search EXCYTOTOXICITY |
7 | FOIX ALAJOUANINE DISEASE | 1 | 50% | 1% | 1 | Search FOIX+ALAJOUANINE+DISEASE | Search FOIX+ALAJOUANINE+DISEASE |
8 | NEURONAL LESION | 1 | 50% | 1% | 1 | Search NEURONAL+LESION | Search NEURONAL+LESION |
9 | THERMAL ANALYSIS TG DSC | 1 | 50% | 1% | 1 | Search THERMAL+ANALYSIS+TG+DSC | Search THERMAL+ANALYSIS+TG+DSC |
10 | CENTRAL NERVOUS DISORDER | 0 | 33% | 1% | 1 | Search CENTRAL+NERVOUS+DISORDER | Search CENTRAL+NERVOUS+DISORDER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BENZOPYRAN ANALOG | 8 | 75% | 4% | 6 |
2 | DIENCEPHALIC ANGIOENCEPHALOPATHY | 2 | 67% | 1% | 2 |
3 | NEOCORTICAL INFARCTS | 1 | 50% | 1% | 2 |
4 | LUBELUZOLE | 1 | 18% | 5% | 7 |
5 | KR 31378 | 1 | 33% | 1% | 2 |
6 | BENZOPYRANYL CYANOGUANIDINES | 1 | 50% | 1% | 1 |
7 | COGNITIVE BEHAVIORAL DEFICITS | 1 | 50% | 1% | 1 |
8 | KR 31543 | 1 | 50% | 1% | 1 |
9 | ISCHEMIA REPERFUSION DAMAGE | 1 | 25% | 1% | 2 |
10 | GV150526 | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
PHOLCODINE | 1988 | 9 | 8 | 63% |
Considerations on age-associated memory impairment. | 1996 | 0 | 11 | 55% |
A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients | 2008 | 6 | 57 | 9% |
Consensus review. Pharmacological neuroprotection in cerebral ischemia: is it still a therapeutic option? | 2003 | 8 | 93 | 6% |
Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke | 2006 | 17 | 58 | 5% |
Current status and perspectives on the development of neuroprotectants for ischemic cerebrovascular disease | 2003 | 1 | 38 | 8% |
Glutamate antagonists in therapy of stroke | 1998 | 29 | 53 | 4% |
Therapeutic advances in acute ischaemic stroke | 1999 | 2 | 57 | 5% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AGROPHARMA | 7 | 46% | 9.0% | 12 |
2 | 21ST CENTURY FRONTIER PROGRAM | 4 | 75% | 2.2% | 3 |
3 | PROD PHARMACEUT RAW MAT | 1 | 100% | 1.5% | 2 |
4 | BIOL MODULATORS | 1 | 30% | 2.2% | 3 |
5 | NAT SCI NAT SCI | 1 | 50% | 0.7% | 1 |
6 | PHYTOFERMANTAT | 1 | 50% | 0.7% | 1 |
7 | YOOSUNG GU | 1 | 29% | 1.5% | 2 |
8 | PHARM MED OURCES | 0 | 25% | 0.7% | 1 |
9 | SAMSUNG MED SAMSUNG BIOMED | 0 | 10% | 0.7% | 1 |
10 | IST IST NAZL RIC CANCRO IRCCS SMIST | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184474 | CLOMETHIAZOLE//CHLORMETHIAZOLE//CHLOMETHIAZOLE |
2 | 0.0000117774 | NXY 059//INTRAUTERINE ISCHEMIA//ADV MAGNET ONANCE |
3 | 0.0000096002 | EXPERIMENTAL THROMBOEMBOLISM//MIDDLE CEREBRAL ARTERY OCCLUSION//INTRALUMINAL SUTURE |
4 | 0.0000087237 | NIMODIPINE//EMOPAMIL//TC 81 |
5 | 0.0000085002 | GLUTAMATE PYRUVATE TRANSAMINASE GPT//BLOOD GLUTAMATE SCAVENGING//GLUTAMATE OXALOACETATE TRANSAMINASE GOT |
6 | 0.0000079241 | CITICOLINE//CDP CHOLINE//CHOLINE ALPHOSCERATE |
7 | 0.0000079110 | REMACEMIDE//LOSIGAMONE//REMACEMIDE HYDROCHLORIDE |
8 | 0.0000078158 | RILUZOLE//2 CYCLOPROPYLIMINO 3 METHYL 1 3 THIAZOLINE HYDROCHLORIDE//ANTIGLUTAMATE |
9 | 0.0000070993 | GOWERS//QUEEN SQ ARCH MUSEUM//QUEEN SQ LIB |
10 | 0.0000070000 | AFFILIATED OBSTET GYNECOL HOSP//MORPHINE 6 DEHYDROGENASE//ANTIOXIDASE |